Question 1

What is the catalog number for MOG (35-55) (TFA)?

Accepted Answer

The catalog number for MOG (35-55) (TFA) is M29790.

Question 2

What sizes are available for MOG (35-55) (TFA)?

Accepted Answer

MOG (35-55) (TFA) is available in the following size(s): 100 mg, 200 mg, 500 mg, Inquire.

Question 3

How many pack sizes does MOG (35-55) (TFA) come in?

Accepted Answer

MOG (35-55) (TFA) is available in 4 different pack sizes.

Question 4

Is MOG (35-55) (TFA) in stock?

Accepted Answer

MOG (35-55) (TFA) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is MOG (35-55) (TFA) used for?

Accepted Answer

Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) is a minor component of CNS myelin.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 8

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

MOG (35-55) (TFA)

Product Specifications

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Cytokeratin 8/18 (K8.8 + DC10), Biotin conjugate, 0.1mg/mL

Molybdenum

NF-kB p65 Recombinant Rabbit monoclonal Antibody

Human TREmL1 activation kit by CRISPRa

VISTA / B7-H5 / VSIR (Negative Regulator of Immune Response) (VISTA/3007), Biotin conjugate, 0.1mg/mL

Human ALX4 activation kit by CRISPRa